A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830
Clinical trial NCT02751424 · TERMINATED
Trial details
- NCT number
- NCT02751424
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-13
- Primary completion
- 2017-02-02
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.